Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Diffusion Pharmaceuticals Inc. | dffn20160316_8ka.htm |
| EX-23.1 - EXHIBIT 23.1 - Diffusion Pharmaceuticals Inc. | ex23-1.htm |
| EX-99.3 - EXHIBIT 99.3 - Diffusion Pharmaceuticals Inc. | ex99-3.htm |
| EX-99.4 - EXHIBIT 99.4 - Diffusion Pharmaceuticals Inc. | ex99-4.htm |
Exhibit 16.2
March 25, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Diffusion Pharmaceuticals Inc.’s Form 8-K/A dated March 25, 2016, and have the following comments:
|
1. |
We agree with the statements made in paragraphs one through four. |
|
2. |
We have no basis to agree or disagree with the statements made in paragraphs five and six. |
Yours truly,
/s/ Deloitte & Touche LLP